Drug Profile
Research programme: beta-3 adrenoceptor agonists - Molecular Design International
Alternative Names: Beta-3 adrenoceptor agonists research programme - Molecular Design InternationalLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Molecular Design International
- Class
- Mechanism of Action Beta 3 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Obesity in USA
- 07 Oct 2004 The programme is available fro cooperation or licensing (http://www.moleculardesign.com)
- 07 Oct 2004 Preclinical trials in Obesity in USA (unspecified route)